Erratum: Short chain fatty acids and their receptors: New metabolic targets (Translational Research (DOI: 10.1016/j.trsl.2012.10.007));Short chain fatty acids and their receptors: New metabolic targets

Translational Research

Volumn 161, Issue 3, 2013, Pages 131-140

  Layden, Brian T ^a   Angueira, Anthony R ^a   Brodsky, Michael ^a   Durai, Vivek ^a   Lowe, William L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FREE FATTY ACID RECEPTOR 2; FREE FATTY ACID RECEPTOR 3; RECEPTOR; SHORT CHAIN FATTY ACID; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; AMINO ACID METABOLISM; ARTICLE; FERMENTATION; IN VIVO STUDY; INTESTINE EPITHELIUM; LIPID METABOLISM; METABOLIC REGULATION; PANCREAS ISLET; PRIORITY JOURNAL;

EID: 84873932325     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2013.08.006     Document Type: Erratum

References (77)

1. A.Wilkinson ADMa. IUPAC. Compendium of chemical terminology, 2nd ed. (the "Gold Book". McNaught AD Wilkinson A, editors. Oxford: Blackwell Scientific Publications, 1997.
2. S. Talukdar, J.M. Olefsky, and O. Osborn Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases Trends Pharmacol Sci 32 2011 543 550
3. J.M. Wong, R. de Souza, C.W. Kendall, A. Emam, and D.J. Jenkins Colonic health: fermentation and short chain fatty acids J Clin Gastroenterol 40 2006 235 243
4. K. Ahmed, S. Tunaru, and S. Offermanns GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors Trends Pharmacol Sci 30 2009 557 562
5. J. Brent, K. McMartin, S. Phillips, C. Aaron, and K. Kulig Fomepizole for the treatment of methanol poisoning N Engl J Med 344 2001 424 429
6. T. Shimazu, M.D. Hirschey, J.Y. Huang, L.T. Ho, and E. Verdin Acetate metabolism and aging: an emerging connection Mech Ageing Dev 131 2010 511 516
7. T.M. Wolever, R.G. Josse, L.A. Leiter, and J.L. Chiasson Time of day and glucose tolerance status affect serum short-chain fatty acid concentrations in humans Metabolism 46 1997 805 811
8. N. Carrillo-Carrasco, and C. Venditti Propionic acidemia R.A. Pagon, T.D. Bird, C.R. Dolan, K. Stephens, M.P. Adam, 1993 GeneReviews Seattle WA
9. M. Dercksen, M. Duran, L. Ijlst, L.J. Mienie, C.J. Reinecke, and J.P. Ruiter Clinical variability of isovaleric acidemia in a genetically homogeneous population J Inherited Metab Dis 35 2012 1021 1029
10. B.M. Buckley, and D.H. Williamson Origins of blood acetate in the rat Biochem J 166 1977 539 545
11. G.O. Guerrant, M.A. Lambert, and C.W. Moss Analysis of short-chain acids from anaerobic bacteria by high-performance liquid chromatography J Clin Microbiol 16 1982 355 360
12. J.S. Whitehead, Y.S. Kim, and R. Prizont A simple quantitative method to determine short chain fatty acid levels in biological fluids Clinica Chimica Acta 72 1976 315 318
13. D.L. Schooley, F.M. Kubiak, and J.V. Evans Capillary gas chromatographic analysis of volatile and non-volatile organic acids from biological samples as the t-butyldimethylsilyl derivatives J Chromatogr Sci 23 1985 385 390
14. H.M. van Eijk, J.G. Bloemen, and C.H. Dejong Application of liquid chromatography-mass spectrometry to measure short chain fatty acids in blood J Chromatogr 877 2009 719 724
15. J.G. Bloemen, K. Venema, M.C. van de Poll, S.W. Olde Damink, W.A. Buurman, and C.H. Dejong Short chain fatty acids exchange across the gut and liver in humans measured at surgery Clin Nutr (Edinburgh, Scotland) 28 2009 657 661
16. J.H. Cummings, E.W. Pomare, W.J. Branch, C.P. Naylor, and G.T. Macfarlane Short chain fatty acids in human large intestine, portal, hepatic and venous blood Gut 28 1987 1221 1227
17. J.H. Cummings, and H.N. Englyst Measurement of starch fermentation in the human large intestine Can J Physiol Pharmacol 69 1991 121 129
18. J.K. Nicholson, E. Holmes, and J. Kinross Host-gut microbiota metabolic interactions Science 336 2012 1262 1267
19. E. Hijova, and A. Chmelarova Short chain fatty acids and colonic health Bratislavske Lekarske Listy 108 2007 354 358
20. T.M. Wolever, K.B. Schrade, J.A. Vogt, E.B. Tsihlias, and M.I. McBurney Do colonic short-chain fatty acids contribute to the long-term adaptation of blood lipids in subjects with type 2 diabetes consuming a high-fiber diet? Am J Clin Nutr 75 2002 1023 1030
21. T.M. Wolever, and J.L. Chiasson Acarbose raises serum butyrate in human subjects with impaired glucose tolerance Br J Nutr 84 2000 57 61
22. J. Tarini, and T.M. Wolever The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects Appl Physiol Nutr Metab 35 2010 9 16
23. K.R. Freeland, C. Wilson, and T.M. Wolever Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects Br J Nutr 103 2010 82 90
24. I. Sakakibara, T. Fujino, and M. Ishii Fasting-induced hypothermia and reduced energy production in mice lacking acetyl-CoA synthetase 2 Cell Metab 9 2009 191 202
25. E. Pouteau, P. Nguyen, O. Ballevre, and M. Krempf Production rates and metabolism of short-chain fatty acids in the colon and whole body using stable isotopes Proc Nutr Soc 62 2003 87 93
26. X.L. Tang, Y. Wang, D.L. Li, J. Luo, and M.Y. Liu Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets Acta Pharmacologica Sinica 33 2012 363 371
27. G. Vassart, and S. Costagliola G protein-coupled receptors: mutations and endocrine diseases Nat Rev Endocrinol 7 2011 362 372
28. A.J. Brown, S.M. Goldsworthy, and A.A. Barnes The Orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids J Biol Chem 278 2003 11312 11319
29. A. Hirasawa, K. Tsumaya, and T. Awaji Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120 Nat Med 11 2005 90 94
30. C. Venkataraman, and F. Kuo The G-protein coupled receptor, GPR84 regulates IL-4 production by T lymphocytes in response to CD3 crosslinking Immunol Letters 101 2005 144 153
31. G. Swaminath Fatty acid binding receptors and their physiological role in type 2 diabetes Archiv der Pharmazie 341 2008 753 761
32. J.B. Regard, I.T. Sato, and S.R. Coughlin Anatomical profiling of G protein-coupled receptor expression Cell 135 2008 561 571
33. Y.H. Hong, Y. Nishimura, and D. Hishikawa Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43 Endocrinology 146 2005 5092 5099
34. S. Karaki, R. Mitsui, and H. Hayashi Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine Cell Tissue Res 324 2006 353 360
35. S. Karaki, H. Tazoe, and H. Hayashi Expression of the short-chain fatty acid receptor, GPR43, in the human colon J Mol Histol 39 2008 135 142
36. N.E. Nilsson, K. Kotarsky, C. Owman, and B. Olde Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids Biochem Biophys Res Commun 303 2003 1047 1052
37. B.T. Layden, V. Durai, and M.V. Newman Regulation of pancreatic islet gene expression in mouse islets by pregnancy J Endocrinol 207 2010 265 279
38. M.A. Kebede, T. Alquier, M.G. Latour, and V. Poitout Lipid receptors and islet function: therapeutic implications? Diabetes Obes Metab 11 Suppl 4 2009 10 20
39. J.B. Regard, H. Kataoka, and D.A. Cano Probing cell type-specific functions of G(i) in vivo identifies GPCR regulators of insulin secretion J Clin Invest 117 2007 4034 4043
40. J. Schmidt, N.J. Smith, and E. Christiansen Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3 J Biol Chem 286 2011 10628 10640
41. G. Milligan, L.A. Stoddart, and N.J. Smith Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3 Br J Pharmacol 158 2009 146 153
42. I. Kimura, D. Inoue, and T. Maeda Short-chain fatty acids and ketones directly regulate sympathetic nervous system via G protein-coupled receptor 41 (GPR41) Proc Nat Acad Sci U S A 108 2011 8030 8035
43. A. Hirasawa, T. Hara, S. Katsuma, T. Adachi, and G. Tsujimoto Free fatty acid receptors and drug discovery Biol Pharmaceut Bull 31 2008 1847 1851
44. O.C. Velazquez, H.M. Lederer, and J.L. Rombeau Butyrate and the colonocyte. Production, absorption, metabolism, and therapeutic implications Adv Exp Med Biol 427 1997 123 134
45. J.W. Anderson, P. Baird, and R.H. Davis Health benefits of dietary fiber Nutr Rev 67 2009 188 205
46. R.E. Ley, P.J. Turnbaugh, S. Klein, and J.I. Gordon Microbial ecology: human gut microbes associated with obesity Nature 444 2006 1022 1023
47. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, and J.I. Gordon An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 2006 1027 1031
48. A. Schwiertz, D. Taras, and K. Schafer Microbiota and SCFA in Lean and Overweight Healthy Subjects Obesity 18 2009 190 195
49. B.T. Layden, S.K. Yalamanchi, T.M. Wolever, A. Dunaif, and W.L. Lowe Jr. Negative association of acetate with visceral adipose tissue and insulin levels Diabetes Metab Syndrome Obes 5 2012 49 55
50. E.F. Murphy, P.D. Cotter, and S. Healy Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models Gut 59 2010 1635 1642
51. Z. Gao, J. Yin, and J. Zhang Butyrate improves insulin sensitivity and increases energy expenditure in mice Diabetes 58 2009 1509 1517
52. H. Yamashita, K. Fujisawa, and E. Ito Improvement of obesity and glucose tolerance by acetate in type 2 diabetic Otsuka Long-Evans Tokushima Fatty (OLETF) rats Biosci Biotechnol Biochem 71 2007 1236 1243
53. H.V. Lin, A. Frassetto, and E.J. Kowalik Jr. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms PLoS ONE 7 2012 e35240
54. T. Arora, R. Sharma, and G. Frost Propionate. Anti-obesity and satiety enhancing factor? Appetite 56 2011 511 515
55. W. Scheppach, J.H. Cummings, W.J. Branch, and J. Schrezenmeir Effect of gut-derived acetate on oral glucose tolerance in man Clin Sci (Lond) 75 1988 355 361
56. C. Laurent, C. Simoneau, and L. Marks Effect of acetate and propionate on fasting hepatic glucose production in humans Eur J Clin Nutr 49 1995 484 491
57. C.S. Johnston, C.M. Kim, and A.J. Buller Vinegar improves insulin sensitivity to a high-carbohydrate meal in subjects with insulin resistance or type 2 diabetes Diabetes Care 27 2004 281 282
58. C.S. Johnston, and C.A. Gaas Vinegar: medicinal uses and antiglycemic effect Med Gen Med 8 2006 61
59. C.S. Johnston, I. Steplewska, C.A. Long, L.N. Harris, and R.H. Ryals Examination of the antiglycemic properties of vinegar in healthy adults Ann Nutr Metab 56 2010 74 79
60. T.M. Wolever, P. Spadafora, and H. Eshuis Interaction between colonic acetate and propionate in humans Am J Clin Nutr 53 1991 681 687
61. K.R. Freeland, and T.M. Wolever Acute effects of intravenous and rectal acetate on glucagon-like peptide-1, peptide YY, ghrelin, adiponectin and tumour necrosis factor-alpha Br J Nutr 103 2010 460 466
62. M. Horino, L.J. Machlin, F. Hertelendy, and D.M. Kipnis Effect of short-chain fatty acids on plasma insulin in ruminant and nonruminant species Endocrinology 83 1968 118 128
63. H.M. Ximenes, A.E. Hirata, M.S. Rocha, R. Curi, and A.R. Carpinelli Propionate inhibits glucose-induced insulin secretion in isolated rat pancreatic islets Cell Biochem Funct 25 2007 173 178
64. A. Tiengo, A. Valerio, M. Molinari, A. Meneghel, and A. Lapolla Effect of ethanol, acetaldehyde, and acetate on insulin and glucagon secretion in the perfused rat pancreas Diabetes 30 1981 705 709
65. J.W. Anderson, and W.J. Chen Plant fiber. Carbohydrate and lipid metabolism Am J Clin Nutr 32 1979 346 363
66. J.W. Anderson, and A.E. Siesel Hypocholesterolemic effects of oat products Adv Exp Med Biol 270 1990 17 36
67. T.M. Wolever, F. Brighenti, D. Royall, A.L. Jenkins, and D.J. Jenkins Effect of rectal infusion of short chain fatty acids in human subjects Am J Gastroenterol 84 1989 1027 1033
68. J.R. Crouse, C.D. Gerson, L.M. DeCarli, and C.S. Lieber Role of acetate in the reduction of plasma free fatty acids produced by ethanol in man J Lipid Res 9 1968 509 512
69. A.O. Akanji, and T.D. Hockaday Acetate tolerance and the kinetics of acetate utilization in diabetic and nondiabetic subjects Am J Clin Nutr 51 1990 112 118
70. J. Fernandes, J. Vogt, and T.M. Wolever Intravenous acetate elicits a greater free fatty acid rebound in normal than hyperinsulinaemic humans Eur J Clin Nutr 66 2012 1029 1034
71. C.S. Venter, H.H. Vorster, and J.H. Cummings Effects of dietary propionate on carbohydrate and lipid metabolism in healthy volunteers Am J Gastroenterol 85 1990 549 553
72. R.S. Wright, J.W. Anderson, and S.R. Bridges Propionate inhibits hepatocyte lipid synthesis Proc Soc Exp Biol Med Soc Exp Biol Med (New York, NY) 195 1990 26 29
73. M. Bjursell, T. Admyre, and M. Goransson Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet Am J Physiol 300 2010 E211 E220
74. Wilbur KL, Wainscott DB, Hu CC, et al. GPR43 Agonist Stimulate Secretion of GLP-1. American Diabetes Association Meeting 2012.
75. H. Ge, X. Li, and J. Weiszmann Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids Endocrinology 149 2008 4519 4526
76. J. Wu, Z. Zhou, Y. Hu, and S. Dong Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth J Genet Genom 39 2012 375 384
77. I. Moschen, A. Broer, S. Galic, F. Lang, and S. Broer Significance of short chain fatty acid transport by members of the monocarboxylate transporter family (MCT) Neurochem Res 37 2012 2562 2568